NDM Prize Studentships

[AstraZeneca funded studentship with funding from £23,805 p.a. for a 4-year PhD.] This is a collaborative PhD studentship hosted by the Department of Pathology at the University of Cambridge and the AstraZeneca Discovery Centre at Cambridge. The project brings together academic and industry research environments, with the student working across both sites under joint supervision. The research focuses on improved 2A peptide sequences and their use in co-translational separation of polyproteins. T...

The University of Cambridge Department of Pathology, in collaboration with AstraZeneca, is offering a four-year, fully funded PhD studentship beginning 1 October 2027. The project, based at the University of Cambridge and the AstraZeneca Discovery Centre in Cambridge, investigates improved 2A peptides for co-translational separation of polyproteins. 2A peptides enable ribosome skipping, allowing multiple proteins or pathway components to be expressed from a single promoter. The research will inv...

[Fully funded 4-year Norwich Research Park Biosciences Doctoral Training Partnership PhD studentship including tuition fees paid directly to the university, a stipend of £21,805 (2026/27 rate), and a Research Training Support Grant of £5,000 per year.] PhD studentship at the University of East Anglia on AI-led protein design for engineering disease resistance in plants. This project sits within the Norwich Research Park Biosciences Doctoral Training Programme (NRPDTP) and focuses on understandin...

The University of East Anglia’s School of Biological Sciences is offering a funded, full-time PhD studentship in Norwich, United Kingdom, focused on alternative splicing regulation by small nuclear RNA (snRNA) modifications . Based in Dr Alper Akay’s RNA (epi)genetics laboratory, the project will investigate how spliceosomal snRNA modifications regulate RNA splicing and gene-specific splice-site choice. Research will use the nematode Caenorhabditis elegans and human cells to examine effects on t...

PhD studentship at the University of Cambridge in partnership with AstraZeneca: Next-generation targeted protein degradation (TPD) for oncology , focusing on ubiquitin-independent pathways , proteasome-targeting tools, Midnolin biology, cell biology, and biochemistry. The Department of Pharmacology at the University of Cambridge is offering a funded PhD studentship to develop novel approaches for targeted protein degradation in cancer research. The project will be carried out in the lab of Dr Ca...